Reducing waste in collection of quality-of-life data through better reporting: a case study.

EQ-5D Health utility Health-related quality-of-life Meta-analysis Research waste Systematic reviews

Journal

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation
ISSN: 1573-2649
Titre abrégé: Qual Life Res
Pays: Netherlands
ID NLM: 9210257

Informations de publication

Date de publication:
Oct 2022
Historique:
accepted: 03 01 2022
pubmed: 25 1 2022
medline: 16 9 2022
entrez: 24 1 2022
Statut: ppublish

Résumé

This study describes the reporting of the preference-based health-related quality-of-life (HRQOL) instrument, the EQ-5D, and proposes strategies to improve reporting and reduce research waste. The EQ-5D is a validated instrument widely used for health economic evaluation and is useful for informing health policy. As part of a systematic review of papers reporting EQ-5D utility weights in patients with coronary artery disease, we noted the reasons data from some papers could not be reused in a meta-analysis, including whether health utility weights and sufficient statistical details were reported. Research waste was quantified using: (1) the percentage of papers and sample size excluded, and (2) researcher time and cost reviewing poorly reported papers. Our search strategy found 5942 papers. At title and abstract screening 93% were excluded. Of the 379 full text papers screened, 130 papers reported using EQ-5D. Only 46% (60/130) of those studies reported utility weights and/or statistical properties enabling meta-analysis. Only 67% of included papers had reported EQ-5D in the title or abstract. A total sample size of 133,298 was excluded because of poor reporting. The cost of researcher time wasted estimated to be between $3816 and $13,279 for our review. Poor reporting of EQ-5D data creates research waste where potentially useful data are excluded from meta-analyses and economic evaluations. Poor reporting of HRQOL instruments also creates waste due to additional time spent reviewing papers for systematic reviews that are subsequently excluded. Studies using the EQ-5D should report utility weights with appropriate summary statistics to enable reuse in meta-analysis and more robust evidence for health policy. We recommend authors report the HRQOL instrument in the title or abstract in line with current reporting guidelines (CONSORT-PRO and SPIRIT-PRO Extensions) to make it easier for other researchers to find. Validated instruments should also be listed in the Medical Subject Headings (MeSH) to improve cataloguing and retrieval of previous research.

Identifiants

pubmed: 35072906
doi: 10.1007/s11136-022-03079-1
pii: 10.1007/s11136-022-03079-1
pmc: PMC9470638
doi:

Types de publication

Journal Article Meta-Analysis Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

2931-2938

Subventions

Organisme : national health and medical research council
ID : APP1117784

Informations de copyright

© 2022. The Author(s).

Références

Syst Rev. 2016 Aug 17;5(1):140
pubmed: 27535658
Lancet. 2014 Jan 18;383(9913):267-76
pubmed: 24411647
Qual Life Res. 2019 Feb;28(2):321-334
pubmed: 30194626
Lancet. 2014 Jan 18;383(9913):257-66
pubmed: 24411650
Lancet. 2014 Mar 29;383(9923):1124
pubmed: 24679623
J Med Libr Assoc. 2017 Jan;105(1):84-87
pubmed: 28096751
BMJ Open. 2020 Jul 29;10(7):e039311
pubmed: 32727739
Value Health. 2019 Mar;22(3):267-275
pubmed: 30832964
J Health Serv Res Policy. 2005 Oct;10(4):245-50
pubmed: 16259692
JAMA. 2013 Feb 27;309(8):814-22
pubmed: 23443445
Health Qual Life Outcomes. 2009 Mar 31;7:27
pubmed: 19335878
JAMA. 2018 Feb 6;319(5):483-494
pubmed: 29411037
Lancet. 2014 Jan 11;383(9912):156-65
pubmed: 24411644
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
BMJ Open. 2017 Nov 8;7(11):e015888
pubmed: 29122784
Cochrane Database Syst Rev. 2019 Oct 3;10:ED000142
pubmed: 31643080
Trials. 2017 Mar 14;18(1):122
pubmed: 28288676
Lancet. 2009 Jul 4;374(9683):86-9
pubmed: 19525005

Auteurs

Victoria McCreanor (V)

AusHSI, Centre for Healthcare Transformation, Queensland University of Technology, Brisbane, Australia. victoria.mccreanor@qut.edu.au.
Jamieson Trauma Institute, Metro North Health, Herston, Australia. victoria.mccreanor@qut.edu.au.

Elaine Lum (E)

Duke-NUS Medical School, Health Services & Systems Research, Singapore, Singapore.

Nicholas Graves (N)

Duke-NUS Medical School, Health Services & Systems Research, Singapore, Singapore.

Nan Luo (N)

Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore.

William Parsonage (W)

AusHSI, Centre for Healthcare Transformation, Queensland University of Technology, Brisbane, Australia.
Cardiology, Royal Brisbane & Women's Hospital, Herston, Australia.

Adrian Barnett (A)

AusHSI, Centre for Healthcare Transformation, Queensland University of Technology, Brisbane, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH